Fritextsökning
Innehållstyper
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Fem projekt ska minska djurförsök
Får 14 miljoner av Vetenskapsrådet.
-
Rapid and thorough homogenization of samples
MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.
-
VTT in brief
VTT is a broad science cluster with research within applied materials, chemical and biochemical processes, energy, industrial systems management, information an...
-
Nya EU-regler påverkar life science-branschen
Stora regulatoriska förändringar på gång i EU.
-
Nytt konsortium för nano
Skandinavien ska bli känt som ett nanomedicinkluster. Det är vad grundarna till Nanomed North hoppas på. I dag har det nybildade konsortiet ett 50-tal medlemmar...
-
EU-grepp mot Alzheimers
Ett samarbete mellan 24 EU-länder ska ta ett samlat grepp för att hitta sätt att bekämpa neurodegenerativa sjukdomar.
-
Cancerskydd påverkas av gener
Folsyratillskott skyddar många kvinnor mot bröstcancer men för vissa ökar risken, visar ny forskning.
-
Nanotechforskare får proof of concept-bidrag
Winnie E. Svendsen är en av sex forskare vid Danmarks Tekniska Universitet, DTU, som får dela på 5,4 miljoner svenska kronor från the Proof-of-Concept Fund.
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Fewer visitors but satisfied exhibitors
Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.
-
Kattforskare får pris
Jonas Wensman belönas för sin forskning kring en neurologisk sjukdom som främst drabbar utekatter.
-
Hello Johan Billiet...
...Flanders Investment and Trade Agency, why are there so many Belgian companies represented at Biotech Forum?
-
"An open mind is the key to successful meetings"
Meeting in person is irreplaceble when it comes to finding a new partner. Johan Ohlsson at Venture Valuation is happy with his meetings at Biotech Forum so far ...
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Hallå där Mehrdad Motamedi...
...på Arterion, hur arbetar ni med validering?
-
Lyckad riskkapitalhöst för amerikansk biotech
Uppåt för biotechbolagen och neråt för medtech och läkemedel. Så ser fördelningen av amerikanskt riskkapital ut för fjärde kvartalet 2009.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
BREAKING